Easton Pharmaceuticals Acquires Interest in Development Project With in Excess of $30 Million in Profit TORONTO, ON, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces that it has entered into an Agreement to acquire an interest in a Real Estate Development Project...